<生产厂家 价格>

非尼拉敏

非尼拉敏用途

苯尼拉明是第一代组胺H1受体拮抗剂,作用于中枢神经系统(CNS),具有镇静和催眠作用。苯尼拉明具有抗肿瘤作用并诱导白血病细胞凋亡。苯尼拉明也是一种安全有效的局部麻醉药,具有止痒作用[1][2][3][4]。

非尼拉敏名称

[ CAS 号 ]:
86-21-5

[ 中文名 ]:
非尼拉敏

[ 英文名 ]:
Pheniramine

[中文别名 ]:

[英文别名 ]:

非尼拉敏生物活性

[ 描述 ]:

苯尼拉明是第一代组胺H1受体拮抗剂,作用于中枢神经系统(CNS),具有镇静和催眠作用。苯尼拉明具有抗肿瘤作用并诱导白血病细胞凋亡。苯尼拉明也是一种安全有效的局部麻醉药,具有止痒作用[1][2][3][4]。

[ 相关类别 ]:

信号通路 >> 细胞凋亡 >> 细胞凋亡
研究领域 >> 癌症
信号通路 >> 免疫及炎症 >> 组胺受体
研究领域 >> 炎症/免疫
信号通路 >> G 蛋白偶联受体/G 蛋白 >> 组胺受体

[ 靶点 ]

H1 Receptor:1.01 mM (IC50)


[体外研究]

苯尼拉明抑制CYP2D6(特异性P450同工酶),以延迟代谢时间并延长抗组织胺作用[1]。苯尼拉明通过抑制IC50值为1.01 mM的组胺抑制Ca2+流入BC3H-1细胞,并调节细胞Ca2+跨膜作用[2]。苯尼拉明(0.5,1.0 mM;24小时)诱导人T细胞急性淋巴细胞白血病细胞株的细胞凋亡[3]。苯尼拉明(1μM-1 mM;12-48 h)以时间依赖性方式抑制细胞增殖,其抑制浓度IC50s分别为550μM(CCRF-CEM细胞)和420μM的(Jurkat细胞)[3]。细胞凋亡分析[3]细胞株:人T细胞急性淋巴细胞白血病细胞株:CCRF-CEM和Jurkat ALL浓度:0.5,1.0 mM培养时间:24小时结果:诱导细胞凋亡,染色质浓缩并边缘化,核碎片扩散到细胞质中。细胞活性测定[3]细胞株:人T细胞急性淋巴细胞白血病细胞株:CCRF-CEM和Jurkat ALL浓度:1μM-1 mM培养时间:12、24、48小时结果:以时间和剂量依赖性方式抑制细胞增殖和存活。

[体内研究]

芬尼拉明(1.75μM;i.t.)对大鼠产生局部麻醉作用并导致脊髓阻滞[4]。动物模型:Sprague–Dawley大鼠(300-350 g;雄性)[4]剂量:0.30、0.60、0.90、1.50、1.75μM给药:鞘内注射;一次性结果:造成脊髓阻滞,并显示剂量依赖性效应。在1.75μM时,运动功能、本体感觉和伤害感受被100%阻断,动作完全恢复时间分别为41、56和88分钟。

[参考文献]

[1]. Sharma A, et al. Classic histamine H1 receptor antagonists: a critical review of their metabolic and pharmacokinetic fate from a bird's eye view. Curr Drug Metab. 2003 Apr;4(2):105-29.

[2]. Brown RD, et al. Alpha 1-adrenergic and H1-histamine receptor control of intracellular Ca2+ in a muscle cell line: the influence of prior agonist exposure on receptor responsiveness. Mol Pharmacol. 1986 Jun;29(6):531-9.

[3]. Jangi SM, et al. Apoptosis of human T-cell acute lymphoblastic leukemia cells by diphenhydramine, an H1 histamine receptor antagonist. Oncol Res. 2004;14(7-8):363-72.

[4]. Hung CH, et al. Spinal anesthesia with diphenhydramine and pheniramine in rats. Eur J Pharmacol. 2011 Dec 30;673(1-3):20-4.

非尼拉敏物理化学性质

[ 密度 ]:
1.018 g/cm3

[ 沸点 ]:
84 °C20 mm Hg(lit.)

[ 熔点 ]:
30-34 °C(lit.)

[ 分子式 ]:
C16H20N2

[ 分子量 ]:
240.34300

[ 闪点 ]:
179 °F

[ 精确质量 ]:
240.16300

[ PSA ]:
16.13000

[ LogP ]:
3.16520

[ 折射率 ]:
1.556

[ 储存条件 ]:
?20°C

非尼拉敏MSDS

非尼拉敏毒性和生态

CHEMICAL IDENTIFICATION

RTECS NUMBER :
US9625000
CHEMICAL NAME :
Pyridine, 2-(alpha-(2-(dimethylamino)ethyl)benzyl)-
CAS REGISTRY NUMBER :
86-21-5
BEILSTEIN REFERENCE NO. :
0192445
LAST UPDATED :
199612
DATA ITEMS CITED :
4
MOLECULAR FORMULA :
C16-H20-N2
MOLECULAR WEIGHT :
240.38
WISWESSER LINE NOTATION :
T6NJ BYR&2N1&1

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Human - woman
DOSE/DURATION :
14 mg/kg
TOXIC EFFECTS :
Behavioral - hallucinations, distorted perceptions Behavioral - muscle contraction or spasticity
REFERENCE :
MJAUAJ Medical Journal of Australia. (Australasian Medical Pub. Co. Ltd., 71-79 Arundel St., Glebe, N.S.W., Australia) V.1- 1914- Volume(issue)/page/year: 2,110,1976
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
48 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
AEPPAE Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. (Berlin, Ger.) V.110-253, 1925-66. For publisher information, see NSAPCC. Volume(issue)/page/year: 211,328,1950
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
30 mg/kg
TOXIC EFFECTS :
Lungs, Thorax, or Respiration - other changes Endocrine - hyperglycemia Nutritional and Gross Metabolic - body temperature decrease
REFERENCE :
AEPPAE Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. (Berlin, Ger.) V.110-253, 1925-66. For publisher information, see NSAPCC. Volume(issue)/page/year: 211,328,1950 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - 81485 No. of Facilities: 805 (estimated) No. of Industries: 1 No. of Occupations: 1 No. of Employees: 805 (estimated)

非尼拉敏安全信息

[ 符号 ]:

GHS02, GHS06, GHS08

[ 信号词 ]:
Danger

[ 危害声明 ]:
H225-H301 + H311 + H331-H370

[ 警示性声明 ]:
P210-P260-P280-P301 + P310-P311

[ 危害码 (欧洲) ]:
Xi

[ 风险声明 (欧洲) ]:
R36/37/38:Irritating to eyes, respiratory system and skin .

[ 安全声明 (欧洲) ]:
S26-S36/37/39

[ 危险品运输编码 ]:
1759

[ WGK德国 ]:
3

[ 包装等级 ]:
III

[ 危险类别 ]:
8

[ 海关编码 ]:
2933399090

非尼拉敏合成路线

非尼拉敏上下游产品

非尼拉敏海关

[ 海关编码 ]: 2933399090

[ 中文概述 ]:
2933399090. 其他结构含非稠合吡啶环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%

[ 申报要素 ]: 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期

[ Summary ]:
2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

非尼拉敏文献

Assessment of protective effects of methylprednisolone and pheniramine maleate on reperfusion injury in kidney after distant organ ischemia: a rat model.

Ann. Vasc. Surg. 26(4) , 559-65, (2012)

Ischemia/reperfusion (I/R) injury of tissues is a common problem that cardiovascular surgeons are faced with. Suppression of inflammation, which plays an important role in the pathogenesis of I/R inju...

Artificial neural network combined with principal component analysis for resolution of complex pharmaceutical formulations.

Chem. Pharm. Bull. 59(1) , 35-40, (2011)

A chemometric approach based on the combined use of the principal component analysis (PCA) and artificial neural network (ANN) was developed for the multicomponent determination of caffeine (CAF), mep...

C7a, a biphosphinic cyclopalladated compound, efficiently controls the development of a patient-derived xenograft model of adult T cell leukemia/lymphoma.

Viruses 3(7) , 1041-58, (2011)

Adult T-cell leukemia/lymphoma (ATLL) is a highly aggressive disease that occurs in individuals infected with the human T lymphotropic virus type 1 (HTLV-1). Patients with aggressive ATLL have a poor ...


更多文献

相关化工产品/化学物质:

相关药品:

推荐生产厂家/供应商:

公司名:西安瑞成医药科技有限责任公司

区域:西安市未央区

价格:
¥需询单/1kg

联系人:郭经理

产品详情:Pheniramine Base


查看所有供应商请点击:

非尼拉敏供应商


相关化合物

【非尼拉敏】化源网提供非尼拉敏CAS号86-21-5,非尼拉敏MSDS及其说明、性质、英文名、生产厂家、作用/用途、分子量、密度、沸点、熔点、结构式等。CAS号查询非尼拉敏上化源网,专业又轻松。>>电脑版:非尼拉敏

标题:非尼拉敏_MSDS_用途_密度_非尼拉敏CAS号【86-21-5】_化源网 地址:https://www.chemsrc.com/amp/cas/86-21-5_832917.html